Inhibrx, Inc. posts annual revenue of $2.19 million in 2022
Key fundamental financials
profit of $145.23 million
Revenue of $2.19 million
Inhibrx, Inc. [INBX] has reported $145.23 million profit for the fiscal year ending Dec 31, 2022.
Revenue for the year was $2.19 million with operating income of $129.12 million.
The Lajolla, California (CA)-based company operating in the biological products, except diagnostic substances sector with 141 employees has total shareholders equity of $58.06 million.